Stocks Report from StockHotTips.com

EpiCept Corporation (Nasdaq:EPCT) announced that the continuation of its annual shareholder meeting will be accessible to investors via webcast. The annual meeting will be held on Monday, June 27, 2011 at 10:00 AM EDT at EpiCept's corporate offices in Tarrytown, New York. Investors may access the webcast through the EpiCept website at http://www.epicept.com beginning at 10:00 a.m. EDT. The webcast will be available for replay for 90 days.

EpiCept Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of cancer and pain in the United States and Germany. Its lead product, Ceplene, is used for the treatment of acute myeloid leukemia.

************************

 Cleantech Transit Inc (CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit Inc has expanded its focus to invest directly in specific green projects that could maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech Transit Inc. has selected to invest in Phoenix Energy (www.phoenixenergy.net).

Cleantech Transit, Inc. is pleased to announce it has completed an agreement whereby it can earn a larger ownership percentage in the 500 KW bio mass Merced Project than previously announced.

Cleantech can now earn in up to 40% of the Merced Project up from the original 25% the Company announced. The 40% ownership stake will be based on the total cost incurred to the Project to date, in addition Cleantech can invest the in the Series B shares of Phoenix Energy equal to or greater to the direct investment made in 500 KW project.

Biomass energy is energy produced by burning biomass. Biomass is a broad category of material encompassing all the living matter in an area. Wood, crops and crop waste, and wastes of plant, mineral, and animal matter comprise much of an area's biomass. Much of this material is considered "garbage" and ends up in landfills.

It has been estimated that 90 percent of U.S. waste products could be burned, thereby providing the equivalent energy of 100 million tons of coal (20 percent of waste products will not burn though they can be recycled). In Western Europe, there are more than 200 power plants that burn rubbish (garbage) to produce electricity.

Biomass can also be converted into energy-providing biofuels, such as biogas, methane, methanol, and ethanol.

For more information about CLNO, visit www.cleantechtransitinc.com

**********************

 Blue Gold Beverages, Inc. (BGBV)

Tea contains phytochemicals that help the body fight certain cancers. Tea can also help you maintain healthy blood cholesterol levels by inhibiting oxidation of LDL (low density lipoproteins, or "bad cholesterol). Tea can also help boost your immune system. Tea is also rich in fluoride, and contains approximately the same amount as fluoridated water.

Specific polyphenols such as catechins, found naturally in tea, may have even stronger antioxidant properties than many fruits and vegetables. Again, antioxidants are believed to neutralize free radicals that scientists believe play a role in development of certain types of cancer and heart disease.

Drinking tea may help your tooth enamel remain healthy and inhibit the formation of cavities and plaque. Fluoride is also essential for keeping your bones strong and healthy.

Blue Gold Beverages, Inc. is a leading high end producer of private label water and specialty beverages in North America. Some of our products include all natural sodas, teas, non-alcoholic wine coolers and energy drinks. Blue Gold Beverages head office situated in Montreal, Quebec, Canada, we use 3rd party bottling plants strategically located across North America depending on the geographical location of our clients. With the recent acquisition of TY Recycling, Blue Gold Beverages has entered into the polymer recycling business, selling PET and Nylon waste. This is in-line with the company's strategy of becoming environmentally responsible by eliminating its carbon footprint, and increasing shareholder value.

Blue Gold Beverages, Inc. is a leading high end producer of private label water and specialty beverages in North America. Some of our products include all natural sodas, teas, non-alcoholic wine coolers and energy drinks. Blue Gold Beverages head office situated in Montreal, Quebec, Canada.

Blue Gold Beverages, Inc. (BGBV) is pleased to announce it s wholly owned subsidiary EPIC Nutrition, Inc. has launched Goodnight™ 2.5 fl oz sleep shots. The product contains a proprietary blend of active ingredients and is one of the early entrants in the liquid delivery system of sleep aids. www.goodnightshot.com

Goodnight's proprietary formula promotes slow-wave "DELTA" or deep sleep. "A Goodnight's sleep is often the best way to help cope with stress, solve problems and recover from illness." continues Mr. Movic. "Goodnight will be supported by an interactive website www.goodnightshot.com, QR reader capabilities and social networking sites Twitter and Facebook providing updates promoting health sleeping habits, product promotions and discounts."

Statistics from Marketdata Enterprises, Inc. (www.marketdataenterprises.com), leading independent market research publisher reports 58% or more than 175 million of all Americans are estimated to experience insomnia symptoms or sleep disorders. Marketdata estimates that the U.S. sleep market was worth US$ 23.7 billion in 2007.

For more information BGBV, please visit: http://www.bluegoldbeverages.com

*****************************

Theratechnologies Inc. (NASDAQ:THER) announced that it has filed a New Drug Submission (NDS) with the Therapeutic Products Directorate of Health Canada for EGRIFTA® (tesamorelin for injection). EGRIFTA® is an analogue of the growth hormone-releasing factor (GRF) proposed for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. Currently, there are no approved treatments for lipodystrophy in HIV patients available in Canada.

Theratechnologiesis a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at www.theratech.com.

************************

CEL-SCI Corporation (AMEX:CVM) announced that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine®, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan. The Site Initiation Visit is the final step before patient enrollment begins. The Multikine to be used in the study is being delivered this week to Taiwan, and patient enrollment is expected to start soon.

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine. CEL-SCI is also developing an immunotherapy (LEAPS-H1N1-DC) to treat H1N1 hospitalized patients and a vaccine (CEL-2000) for Rheumatoid Arthritis using its LEAPS technology platformFor more information, please visit www.cel-sci.com.

*******************************************
Sign-Up For Free Hot Stock Alerts At http://stockhottips.com/signup

*******************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. StockHotTips.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://stockhottips.com/disclaimer)is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB). Crown Equity Holdings Inc. (CRWE.OB) has received seven thousand five hundred dollars ($7,500) in cash from a third party (9186 2780 Quebec Inc) for 1 week of media advertisement services for Blue Gold Beverages, Inc. (BGBV).

http://www.flixya.com/blog/3153293/EPCT-CLNO-BGBV-THER-CVM-Stocks-Report-from-StockHotTipscom